Business Context and Reporting Period
This Form 6-K filing by Tiziana Life Sciences Ltd covers the period ending January 31, 2025. The report addresses a regulatory notice received from the Nasdaq Stock Market LLC regarding the company's listing status.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a listing deficiency rather than a financial results statement.
Material Changes
On January 29, 2025, the Company received a notice from Nasdaq stating it is not in compliance with the $1.00 Minimum Bid Price Requirement (Listing Rule 5550(a)(2)). This is a material change in the company's regulatory standing regarding its stock listing.
Guidance, Outlook, and Risks
- Compliance Deadline: The Company has 180 days, until July 28, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 per share for ten consecutive business days.
- Current Status: The notice is a notification of deficiency and does not currently affect the listing or trading of the Company's securities.
- Management Action: Tiziana intends to monitor the closing bid price and may consider available options to regain compliance.
- Contingency: If compliance is not met by the deadline, the Company may be afforded an additional 180-day period to regain compliance.
Investor Verification Checklist
- Verify the current closing bid price of Tiziana Life Sciences Ltd common shares against the $1.00 threshold.
- Monitor future announcements regarding any stock splits or other corporate actions intended to address the bid price deficiency.
- Confirm the status of the listing on the Nasdaq Capital Market as the July 28, 2025, deadline approaches.